IBDEI2JU ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,42752,1,4,0)
 ;;=4^M92.61
 ;;^UTILITY(U,$J,358.3,42752,2)
 ;;=^5015236
 ;;^UTILITY(U,$J,358.3,42753,0)
 ;;=Z47.89^^192^2144^16
 ;;^UTILITY(U,$J,358.3,42753,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42753,1,3,0)
 ;;=3^Orthopedic aftercare, oth
 ;;^UTILITY(U,$J,358.3,42753,1,4,0)
 ;;=4^Z47.89
 ;;^UTILITY(U,$J,358.3,42753,2)
 ;;=^5063032
 ;;^UTILITY(U,$J,358.3,42754,0)
 ;;=M19.072^^192^2144^18
 ;;^UTILITY(U,$J,358.3,42754,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42754,1,3,0)
 ;;=3^Osteoarthritis,Left Ankle/Foot,Primary
 ;;^UTILITY(U,$J,358.3,42754,1,4,0)
 ;;=4^M19.072
 ;;^UTILITY(U,$J,358.3,42754,2)
 ;;=^5010821
 ;;^UTILITY(U,$J,358.3,42755,0)
 ;;=M19.071^^192^2144^19
 ;;^UTILITY(U,$J,358.3,42755,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42755,1,3,0)
 ;;=3^Osteoarthritis,Right Ankle/Foot,Primary
 ;;^UTILITY(U,$J,358.3,42755,1,4,0)
 ;;=4^M19.071
 ;;^UTILITY(U,$J,358.3,42755,2)
 ;;=^5010820
 ;;^UTILITY(U,$J,358.3,42756,0)
 ;;=M19.90^^192^2144^20
 ;;^UTILITY(U,$J,358.3,42756,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42756,1,3,0)
 ;;=3^Osteoarthritis,Unspec Site
 ;;^UTILITY(U,$J,358.3,42756,1,4,0)
 ;;=4^M19.90
 ;;^UTILITY(U,$J,358.3,42756,2)
 ;;=^5010853
 ;;^UTILITY(U,$J,358.3,42757,0)
 ;;=M96.0^^192^2145^14
 ;;^UTILITY(U,$J,358.3,42757,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42757,1,3,0)
 ;;=3^Pseudarthrosis after fusion or arthrodesis
 ;;^UTILITY(U,$J,358.3,42757,1,4,0)
 ;;=4^M96.0
 ;;^UTILITY(U,$J,358.3,42757,2)
 ;;=^5015373
 ;;^UTILITY(U,$J,358.3,42758,0)
 ;;=R20.2^^192^2145^1
 ;;^UTILITY(U,$J,358.3,42758,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42758,1,3,0)
 ;;=3^Paresthesia of skin
 ;;^UTILITY(U,$J,358.3,42758,1,4,0)
 ;;=4^R20.2
 ;;^UTILITY(U,$J,358.3,42758,2)
 ;;=^5019280
 ;;^UTILITY(U,$J,358.3,42759,0)
 ;;=I87.003^^192^2145^12
 ;;^UTILITY(U,$J,358.3,42759,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42759,1,3,0)
 ;;=3^Postthrom syndr w/o compl of bilat lwr extrem
 ;;^UTILITY(U,$J,358.3,42759,1,4,0)
 ;;=4^I87.003
 ;;^UTILITY(U,$J,358.3,42759,2)
 ;;=^5008029
 ;;^UTILITY(U,$J,358.3,42760,0)
 ;;=I87.001^^192^2145^11
 ;;^UTILITY(U,$J,358.3,42760,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42760,1,3,0)
 ;;=3^Postrhomb syndr w/o compl of rt lwr extrem
 ;;^UTILITY(U,$J,358.3,42760,1,4,0)
 ;;=4^I87.001
 ;;^UTILITY(U,$J,358.3,42760,2)
 ;;=^5008027
 ;;^UTILITY(U,$J,358.3,42761,0)
 ;;=I80.01^^192^2145^8
 ;;^UTILITY(U,$J,358.3,42761,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42761,1,3,0)
 ;;=3^Phlebitis & Thromboph,Right Lower Sprfcl Vessels
 ;;^UTILITY(U,$J,358.3,42761,1,4,0)
 ;;=4^I80.01
 ;;^UTILITY(U,$J,358.3,42761,2)
 ;;=^5007821
 ;;^UTILITY(U,$J,358.3,42762,0)
 ;;=I80.02^^192^2145^6
 ;;^UTILITY(U,$J,358.3,42762,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42762,1,3,0)
 ;;=3^Phlebitis & Thromboph,Left Lower Sprfcl Vessels
 ;;^UTILITY(U,$J,358.3,42762,1,4,0)
 ;;=4^I80.02
 ;;^UTILITY(U,$J,358.3,42762,2)
 ;;=^5007822
 ;;^UTILITY(U,$J,358.3,42763,0)
 ;;=I80.03^^192^2145^4
 ;;^UTILITY(U,$J,358.3,42763,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42763,1,3,0)
 ;;=3^Phlebitis & Thromboph,Bilateral Lower Sprfcl Vessels
 ;;^UTILITY(U,$J,358.3,42763,1,4,0)
 ;;=4^I80.03
 ;;^UTILITY(U,$J,358.3,42763,2)
 ;;=^5007823
 ;;^UTILITY(U,$J,358.3,42764,0)
 ;;=I80.11^^192^2145^7
 ;;^UTILITY(U,$J,358.3,42764,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42764,1,3,0)
 ;;=3^Phlebitis & Thromboph,Right Femoral Vein
 ;;^UTILITY(U,$J,358.3,42764,1,4,0)
 ;;=4^I80.11
 ;;^UTILITY(U,$J,358.3,42764,2)
 ;;=^5007825
 ;;^UTILITY(U,$J,358.3,42765,0)
 ;;=I80.12^^192^2145^5
 ;;^UTILITY(U,$J,358.3,42765,1,0)
 ;;=^358.31IA^4^2
